The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents: A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials
Abstract
Background—: Drug-eluting stents (DES) have been in clinical use for nearly a decade; however, the relative short- and long-term efficacy and safety of DES compared with bare-metal stents (BMS) and among the DES types are less well defined. Methods and Results—: PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) were searched for randomized clinical trials, until March 2012, that compared any of the Food and Drug Administration–approved durable stent and polymer DES (sirolimus-eluting stent [SES], paclitaxel-eluting stent [PES], everolimus-eluting stent [EES], zotarolimus-eluting stent [ZES], and ZES-Resolute [ZES-R]) with each other or against BMS for de novo coronary lesions, enrolling at least 100 patients and with follow-up of at least 6 months. Short-term (≤1 year) and long-term efficacy (target-vessel revascularization, target-lesion revascularization) and safety (death, myocardial infarction, stent thrombosis) outcomes were evaluated and trial-level data pooled by both mixed-treatment comparison and direct comparison analyses. From 76 randomized clinical trials with 117 762 patient-years of follow-up, compared with BMS, each DES reduced long-term target-vessel revascularization (39%–61%), but the magnitude varied by DES type (EES∼SES∼ZES-R>PES∼ZES>BMS), with a >42% probability that EES had the lowest target-vessel revascularization rate. There was no increase in the risk of any long-term safety outcomes, including stent thrombosis, with any DES (versus BMS). In addition, there was reduction in myocardial infarction (all DES except PES versus BMS) and stent thrombosis (with EES versus BMS: Rate ratio, 0.51; 95% credibility interval, 0.35–0.73). The safest DES appeared to be EES (>86% probability), with reduction in myocardial infarction and stent thrombosis compared with BMS. Short-term outcomes were similar to long-term outcomes, with SES, ZES-R, and everolimus-eluting stent being the most efficacious and EES being the safest stent. Conclusions—: DES are highly efficacious at reducing the risk of target-vessel revascularization without an increase in any safety outcomes, including stent thrombosis. However, among the DES types, there were considerable differences, such that EES, SES, and ZES-R were the most efficacious and EES was the safest stent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224
Morice, M.-C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012843 · Cited by 4,033
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Bhatt, D. L., Fox, K. A. A., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060989 · Cited by 2,837
Self-citationA Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
Stone, G. W., Ellis, S. G., Cox, D. A., Hermiller, J., O'Shaughnessy, C., Mann, J. T., Turco, M., Caputo, R., Bergin, P., Greenberg, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032441 · Cited by 2,749
Pathology of Drug-Eluting Stents in Humans
Joner, M., Finn, A. V., Farb, A., Mont, E. K., Kolodgie, F. D., Ladich, E., Kutys, R., Skorija, K., Gold, H. K., & Virmani, R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.042 · Cited by 2,744
Combination of direct and indirect evidence in mixed treatment comparisons
Lu, G., & Ades, A. E. (2004) · Statistics in Medicine · doi:10.1002/sim.1875 · Cited by 2,166
Simultaneous comparison of multiple treatments: Combining direct and indirect evidence.
Caldwell, D. M., Ades, A. E., & Higgins, J. P. T. (2005) · BMJ · doi:10.1136/bmj.331.7521.897 · Cited by 1,600
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
McFadden, E. P., Stabile, E., Regar, E., Cheneau, E., Ong, A. T., Kinnaird, T., Suddath, W. O., Weissman, N. J., Torguson, R., Kent, K. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17275-9 · Cited by 1,436
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
Stettler, C., Wandel, S., Allemann, S., Kastrati, A., Morice, M. C., Schömig, A., Pfisterer, M. E., Stone, G. W., Leon, M. B., de Lezo, J. S., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61444-5 · Cited by 1,428
Colombo, A., Drzewiecki, J., Banning, A., Grube, E., Hauptmann, K., Silber, S., Dudek, D., Fort, S., Schiele, F., Zmudka, K., et al. (2003) · Circulation · doi:10.1161/01.cir.0000086926.62288.a6 · Cited by 1,016
Schofer, J., Schlüter, M., Gershlick, A. H., Wijns, W., Garcia, E., Schampaert, E., & Breithardt, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14462-5 · Cited by 955
Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease
Stone, G. W., Rizvi, A., Newman, W., Mastali, K., Wang, J. C., Caputo, R., Doostzadeh, J., Cao, S., Simonton, C. A., Sudhir, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910496 · Cited by 902
Camenzind, E., Steg, P. G., & Wijns, W. (2007) · Circulation · doi:10.1161/circulationaha.106.666800 · Cited by 818
Bhatt, D. L., Flather, M. D., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.025 · Cited by 805
Self-citationStone, G. W., Ellis, S. G., Cannon, L., Mann, J. T., Greenberg, J. D., Spriggs, D., O'Shaughnessy, C. D., DeMaio, S., Hall, P., Popma, J. J., et al. (2005) · JAMA · doi:10.1001/jama.294.10.1215 · Cited by 765
Biondi-Zoccai, G. G. L., Lotrionte, M., Agostoni, P., Abbate, A., Fusaro, M., Burzotta, F., Testa, L., Sheiban, I., & Sangiorgi, G. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl334 · Cited by 733
Self-citationKedhi, E., Joesoef, K. S., McFadden, E., Wassing, J., van Mieghem, C., Goedhart, D., & Smits, P. C. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62127-9 · Cited by 687
Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents
Serruys, P. W., Silber, S., Garg, S., van Geuns, R. J., Richardt, G., Buszman, P. E., Kelbæk, H., van Boven, A. J., Hofma, S. H., Linke, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1004130 · Cited by 670
A note on graphical presentation of estimated odds ratios from several clinical trials
Galbraith, R. F. (1988) · Statistics in Medicine · doi:10.1002/sim.4780070807 · Cited by 663
Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization
Windecker, S., Remondino, A., Eberli, F. R., Jüni, P., Räber, L., Wenaweser, P., Togni, M., Billinger, M., Tüller, D., Seiler, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051175 · Cited by 593
Stone, G. W. (2008) · JAMA · doi:10.1001/jama.299.16.1903 · Cited by 582
Schampaert, E., Cohen, E. A., Schlüter, M., Reeves, F., Traboulsi, M., Title, L. M., Kuntz, R. E., & Popma, J. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.01.024 · Cited by 575
Bayesian approaches to random-effects meta-analysis: a comparative study
Smith, T. C., Spiegelhalter, D. J., & Thomas, A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780142408 · Cited by 568
Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction
Spaulding, C., Henry, P., Teiger, E., Beatt, K., Bramucci, E., Carrié, D., Slama, M. S., Merkely, B., Erglis, A., Margheri, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062006 · Cited by 564
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
Park, S.-J., Park, D.-W., Kim, Y.-H., Kang, S.-J., Lee, S.-W., Lee, C. W., Han, K.-H., Park, S.-W., Yun, S.-C., Lee, S.-G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001266 · Cited by 511
Late Thrombosis of Drug-Eluting Stents: A Meta-Analysis of Randomized Clinical Trials
Bavry, A. A., Kumbhani, D. J., Helton, T. J., Borek, P. P., Mood, G. R., & Bhatt, D. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.023 · Cited by 490
Self-citationFajadet, J., Wijns, W., Laarman, G.-J., Kuck, K.-H., Ormiston, J., Münzel, T., Popma, J. J., Fitzgerald, P. J., Bonan, R., & Kuntz, R. E. (2006) · Circulation · doi:10.1161/circulationaha.105.591206 · Cited by 464
Morice, M.-C., Colombo, A., Meier, B., Serruys, P., Tamburino, C., Guagliumi, G., Sousa, E., Stoll, H.-P., & REALITY Trial Investigators, F. T. (2006) · JAMA · doi:10.1001/jama.295.8.895 · Cited by 458
Stone, G. W., Witzenbichler, B., Guagliumi, G., Peruga, J. Z., Brodie, B. R., Dudek, D., Kornowski, R., Hartmann, F., Gersh, B. J., Pocock, S. J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60764-2 · Cited by 452
Paclitaxel-Eluting Stents versus Bare-Metal Stents in Acute Myocardial Infarction
Stone, G. W., Lansky, A. J., Pocock, S. J., Gersh, B. J., Dangas, G., Wong, S. C., Witzenbichler, B., Guagliumi, G., Peruga, J. Z., Brodie, B. R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810116 · Cited by 443
Paclitaxel-Eluting versus Uncoated Stents in Primary Percutaneous Coronary Intervention
Laarman, G. J., Suttorp, M. J., Dirksen, M. T., van Heerebeek, L., Kiemeneij, F., Slagboom, T., van der Wieken, L. R., Tijssen, J. G. P., Rensing, B. J., & Patterson, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062598 · Cited by 437
Bare metal stent restenosis is not a benign clinical entity
Chen, M. S., John, J. M., Chew, D. P., Lee, D. S., Ellis, S. G., & Bhatt, D. L. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.08.011 · Cited by 413
Self-citationRäber, L., Magro, M., Stefanini, G. G., Kalesan, B., van Domburg, R. T., Onuma, Y., Wenaweser, P., Daemen, J., Meier, B., Jüni, P., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.058560 · Cited by 374
Sabaté, M., Jiménez-Quevedo, P., Angiolillo, D. J., Gómez-Hospital, J. A., Alfonso, F., Hernández-Antolín, R., Goicolea, J., Bañuelos, C., Escaned, J., Moreno, R., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.562421 · Cited by 368
Kandzari, D. E., Leon, M. B., Popma, J. J., Fitzgerald, P. J., O’Shaughnessy, C., Ball, M. W., Turco, M., Applegate, R. J., Gurbel, P. A., Midei, M. G., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.035 · Cited by 347
Serruys, P. W. J. C., Ruygrok, P., Neuzner, J., Piek, J. J., Seth, A., Schofer, J. J., Richardt, G., Wiemer, M., Carrié, D., Thuesen, L., et al. (2006) · PubMed · Cited by 346
Kaiser, C., Brunner-La Rocca, H. P., Buser, P. T., Bonetti, P. O., Osswald, S., Linka, A., Bernheim, A., Zutter, A., Zellweger, M., Grize, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67221-2 · Cited by 342
Ardissino, D., Cavallini, C., Bramucci, E., Indolfi, C., Marzocchi, A., Manari, A., Angeloni, G., Carosio, G., Bonizzoni, E., Colusso, S., et al. (2004) · JAMA · doi:10.1001/jama.292.22.2727 · Cited by 314
Valgimigli, M., Percoco, G., Malagutti, P., Campo, G., Ferrari, F., Barbieri, D., Cicchitelli, G., McFadden, E. P., Merlini, F., Ansani, L., et al. (2005) · JAMA · doi:10.1001/jama.293.17.2109 · Cited by 307
Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries
Kaiser, C., Galatius, S., Erne, P., Eberli, F., Alber, H., Rickli, H., Pedrazzini, G., Hornig, B., Bertel, O., Bonetti, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1009406 · Cited by 267
von Birgelen, C., Basalus, M. W. Z., Tandjung, K., van Houwelingen, K. G., Stoel, M. G., Louwerenburg, J. (. W., Linssen, G. C. M., Saïd, S. A. M., Kleijne, M. A. W. J., Sen, H., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.008 · Cited by 250
Leon, M. B., Mauri, L., Popma, J. J., Cutlip, D. E., Nikolsky, E., O'Shaughnessy, C., Overlie, P. A., McLaurin, B. T., Solomon, S. L., Douglas, J. S., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.067 · Cited by 241
Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents
Stone, G. W., Rizvi, A., Sudhir, K., Newman, W., Applegate, R. J., Cannon, L. A., Maddux, J. T., Cutlip, D. E., Simonton, C. A., Sood, P., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.022 · Cited by 229
Suttorp, M. J., Laarman, G. J., Rahel, B. M., Kelder, J. C., Bosschaert, M. A. R., Kiemeneij, F., ten Berg, J. M., Bal, E. T., Rensing, B. J., Eefting, F. D., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.613588 · Cited by 228
Long-Term Clinical Outcomes With Sirolimus-Eluting Coronary Stents
Morice, M.-C., Serruys, P. W., Barragan, P., Bode, C., Van Es, G.-A., Stoll, H.-P., Snead, D., Mauri, L., Cutlip, D. E., & Sousa, E. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.029 · Cited by 224
Menichelli, M., Parma, A., Pucci, E., Fiorilli, R., Felice, F. D., Nazzaro, M. S., Giulivi, A., Alborino, D., Azzellino, A., & Violini, R. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.081 · Cited by 222
Doyle, B., Rihal, C. S., O’Sullivan, C. J., Lennon, R. J., Wiste, H. J., Bell, M., Bresnahan, J., & Holmes, D. R. (2007) · Circulation · doi:10.1161/circulationaha.107.707331 · Cited by 217
Rasmussen, K., Maeng, M., Kaltoft, A., Thayssen, P., Kelbæk, H., Tilsted, H. H., Abildgaard, U., Christiansen, E. H., Engstrøm, T., Krusell, L. R., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60208-5 · Cited by 212
A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent
Stone, G. W., Teirstein, P. S., Meredith, I. T., Farah, B., Dubois, C. L., Feldman, R. L., Dens, J., Hagiwara, N., Allocco, D. J., & Dawkins, K. D. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.016 · Cited by 204
Räber, L., Wohlwend, L., Wigger, M., Togni, M., Wandel, S., Wenaweser, P., Cook, S., Moschovitis, A., Vogel, R., Kalesan, B., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.004762 · Cited by 186
Mehilli, J., Kastrati, A., Wessely, R., Dibra, A., Hausleiter, J., Jaschke, B., Dirschinger, J., & Schömig, A. (2006) · Circulation · doi:10.1161/circulationaha.105.575977 · Cited by 179
Park, D., Kim, Y., Yun, S., Kang, S., Lee, S., Lee, C. W., Park, S., In-Whan, S., Lee, J.-H., Seung-Jea, T., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.086 · Cited by 153
van der Hoeven, B. L., Liem, S., Jukema, J. W., Suraphakdee, N., Putter, H., Dijkstra, J., Atsma, D. E., Bootsma, M., Zeppenfeld, K., Oemrawsingh, P. V., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.056 · Cited by 145
Comparison of Paclitaxel- and Sirolimus-Eluting Stents in Everyday Clinical Practice
Galloe, A. M., Thuesen, L., Kelbæk, H., Thayssen, P., Rasmussen, K., Hansen, P. R., Bligaard, N., Saunamäki, K. I., Junker, A., Aarøe, J., et al. (2008) · JAMA · doi:10.1001/jama.299.4.409 · Cited by 142
Byrne, R. A., Mehilli, J., Iijima, R., Schulz, S., Pache, J., Seyfarth, M., Schömig, A., Kastrati, A., & (ISAR-TEST-2), F. T. I. S. A. A. R. T. E. O. 3. L.-E. S. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehp044 · Cited by 139
Long-Term Safety and Efficacy With Paclitaxel-Eluting Stents
Ellis, S. G., Stone, G. W., Cox, D. A., Hermiller, J. B., O’Shaughnessy, C. D., Mann, T., Turco, M. A., Caputo, R. P., Bergin, P. J., Bowman, T. S., et al. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2009.10.003 · Cited by 129
Bavry, A. A., & Bhatt, D. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60922-8 · Cited by 127
Self-citationSpaulding, C. M., Teíger, E., Commeau, P., Varenne, O., Bramucci, E., Slama, M., Beatt, K., Tirouvanziam, A. M., Poloński, L., Stella, P. R., et al. (2011) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.10.007 · Cited by 124
Byrne, R. A., Kastrati, A., Tiroch, K. A., Schulz, S., Pache, J., Pinieck, S., Maßberg, S., Seyfarth, M., Laugwitz, K., Birkmeier, K. A., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.020 · Cited by 115
The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) Trial
Kelbæk, H., Thuesen, L., Helqvist, S., Kløvgaard, L., Jørgensen, E. O., Aljabbari, S., Saunamäki, K. I., Krusell, L. R., Jensen, G. V. H., Bøtker, H. E., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.045 · Cited by 115
Leon, M. B., Nikolsky, E., Cutlip, D. E., Mauri, L., Liberman, H. A., Wilson, H., Patterson, J., Moses, J. W., & Kandzari, D. E. (2010) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.07.008 · Cited by 108
Final 5-Year Results of the TAXUS II Trial
Silber, S., Colombo, A., BANNING, A. P., Hauptmann, K. E., Drzewiecki, J., Grube, E., Dudek, D., & Baim, D. S. (2009) · Circulation · doi:10.1161/circulationaha.109.849877 · Cited by 108
How Valuable are Multiple Treatment Comparison Methods in Evidence-Based Health-Care Evaluation?
Cooper, N. J., Peters, J., Lai, M. C. W., Jüni, P., Wandel, S., Palmer, S., Paulden, M., Conti, S., Welton, N. J., Abrams, K. R., et al. (2011) · Value in Health · doi:10.1016/j.jval.2010.09.001 · Cited by 90
Lee, S., Park, S., Kim, Y., Yun, S., Park, D., Lee, C. W., Hong, M., Rhee, K., Chae, J. K., Ko, J., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.056 · Cited by 87
Valgimigli, M., Campo, G. C., Arcozzi, C., Malagutti, P., Carletti, R., Ferrari, F., Barbieri, D., Parrinello, G., Percoco, G., & Ferrari, R. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.029 · Cited by 81
Violini, R., Musto, C., Felice, F. D., Nazzaro, M. S., Cifarelli, A., Petitti, T., & Fiorilli, R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.046 · Cited by 80
Lee, C. W., Park, D., Lee, S., Kim, Y., Hong, M., Kim, J., Park, S., Yun, S., Seong, I. W., Lee, J., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.06.059 · Cited by 68
Kereiakes, D. J., Cannon, L., Feldman, R. L., Popma, J. J., Magorien, R. D., Whitbourn, R., Dauber, I. M., Rabinowitz, A. C., Ball, M. W., Bertolet, B. D., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.011 · Cited by 65
Three-year clinical outcome after primary stenting of totally occluded native coronary arteries
Rahel, B. M., Laarman, G. J., Kelder, J. C., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.08.025 · Cited by 60
Maresta, A., Varani, E., Balducelli, M., Varbella, F., Lettieri, C., Uguccioni, L., Sangiorgio, P., & Biondi‐Zoccai, G. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.01.040 · Cited by 50
Novel Approaches for Preventing or Limiting Events in Diabetic Patients (Naples-Diabetes) Trial
Briguori, C., Airoldi, F., Visconti, G., Focaccio, A., Caiazzo, G., Golia, B., Biondi‐Zoccai, G., Ricciardelli, B., & Condorelli, G. (2011) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.110.959924 · Cited by 46
Menozzi, A., Solinas, E., Ortolani, P., Repetto, A., Saia, F., Piovaccari, G., Manari, A., Magagnini, E., Vignali, L., Bonizzoni, E., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp224 · Cited by 35
Lee, S., Park, S., Kim, Y., Yun, S., Park, D., Lee, C. W., Kang, S., Rhee, K., Chae, J.-K., Ko, J.-K., et al. (2011) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.12.006 · Cited by 34
Cited by
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
2014 ESC/EACTS Guidelines on myocardial revascularization
Kolh, P., Windecker, S., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu366 · Cited by 4,199
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu282 · Cited by 1,656
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease
Stone, G. W., Sabik, J. F., Serruys, P. W., Simonton, C. A., Généreux, P., Puskas, J., Kandzari, D. E., Morice, M.-C., Lembo, N., Brown, W. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610227 · Cited by 1,068
Metadata
- Authors
- Bangalore, S., Kumar, S., Fusaro, M., Amoroso, N., Attubato, M. J., Feit, F., Bhatt, D. L., & Slater, J.
- Venue
- Circulation
- Published
- 2012-06-12
- Volume
- 125
- Issue
- 23
- Pages
- 2873-2891
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2046209971
- Cited by
- 574
- References
- 78
- FWCI
- 70.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.